肿瘤微环境参与肿瘤发生发展及治疗的研究进展
Research Progress of Tumor Microenvironment Involved in Tumor Development and Treatment
DOI: 10.12677/ACM.2023.133636, PDF,   
作者: 仝建宁, 周浩楠：甘肃中医药大学第一临床医学院，甘肃 兰州；呼永华*：甘肃中医药大学第一临床医学院，甘肃 兰州；甘肃中医药大学附属医院肿瘤科，甘肃 兰州；兰州大学第二临床医学院，甘肃 兰州；陈 昊：兰州大学第二临床医学院，甘肃 兰州；王晓宇：甘肃中医药大学第一临床医学院，甘肃，兰州
关键词: 肿瘤微环境；侵袭转移；免疫治疗；Tumor Microenvironment； Invasion and Metastasis； Immunotherapy
摘要: 肿瘤的发生与发展不仅取决于它们本身是代谢过程，还受到肿瘤内部环境的影响。肿瘤的微环境可以被描述为多个因素共同作用的结果，包括间质细胞、周围的非肿瘤细胞、血管、免疫细胞和分子。这些因素之间的交互作用可能会促进肿瘤细胞的增殖，并导致免疫系统的逃逸，从而导致肿瘤的发展和扩散。因此，肿瘤的治疗已经从仅仅关注肿瘤本身的角度转变为关注整个微环境。近年，肿瘤免疫治疗取得一定疗效与微环境的免疫抑制紧密相关。因此，本文将阐述有关肿瘤微环境影响肿瘤生长转移及治疗的相关研究进展，探索改善免疫治疗效果的理论基础。
Abstract: The occurrence and development of tumors not only depend on their own metabolic processes, but also be affected by the internal environment of tumors. The tumor microenvironment can be de-scribed as the result of a combination of factors, including stromal cells, surrounding non-tumor cells, blood vessels, immune cells, and molecules. The interaction between these factors may pro-mote the proliferation of tumor cells and lead to the escape of the immune system, which leads to the development and spread of tumors. As a result, tumor treatment has shifted from focusing solely on the tumor itself to focusing on the entire microenvironment. In recent years, the efficacy of tumor immunotherapy is closely related to the immunosuppression of microenvironment. There-fore, this paper will elaborate relevant research progress on the effect of tumor microenvironment on tumor growth and metastasis and treatment, and explore the theoretical basis for improving the effect of immunotherapy.
文章引用：仝建宁, 呼永华, 陈昊, 王晓宇, 周浩楠. 肿瘤微环境参与肿瘤发生发展及治疗的研究进展[J]. 临床医学进展, 2023, 13(3): 4437-4442. https://doi.org/10.12677/ACM.2023.133636

参考文献

[1] Bejarano, L., Jordāo, M.J.C. and Joyce, J.A. (2021) Therapeutic Targeting of the Tumor Microenvironment. Cancer Discovery, 11, 933-959. [Google Scholar] [CrossRef] 
[2] Herbst, R.S., Giaccone, G., de Ma-rinis, F., et al. (2020) Atezolizumab for First-Line Treatment of PD-L1-Selected Patients with NSCLC. The New England Journal of Medicine, 383, 1328-1339. [Google Scholar] [CrossRef] 
[3] Qiu, G.Z., Jin, M.Z., Dai, J.X., et al. (2017) Reprogramming of the Tumor in the Hypoxic Niche: The Emerging Concept and Associated Therapeu-tic Strategies. Trends in Pharmacological Sciences, 38, 669-686. [Google Scholar] [CrossRef] [PubMed]
[4] Biffi, G. and Tuveson, D.A. (2021) Diversity and Biology of Can-cer-Associated Fibroblasts. Physiological Reviews, 101, 147-176. [Google Scholar] [CrossRef] [PubMed]
[5] Affo, S., Nair, A., Brundu, F., et al. (2021) Promotion of Chol-angiocarcinoma Growth by Diverse Cancer-Associated Fibroblast Subpopulations. Cancer Cell, 39, 883. [Google Scholar] [CrossRef] [PubMed]
[6] Cadamuro, M., Nardo, G., Indraccolo, S., et al. (2013) Platelet De-rived Growth Factor-D and Rho GTPases Regulate Recruitment of Cancer-Associated Fibroblasts in Cholangiocarcino-ma. Hepatology, 58, 1042-1053. [Google Scholar] [CrossRef] [PubMed]
[7] Sahai, E., Astsaturov, I., Cukierman, E., et al. (2020) A Framework for Advancing Our Understanding of Cancer-Associated Fibroblasts. Nature Reviews Cancer, 20, 174-186. [Google Scholar] [CrossRef] [PubMed]
[8] Chen, Z., Zhou, L., Liu, L., et al. (2020) Single-Cell RNA Se-quencing Highlights the Role of Inflammatory Cancer-Associated Fibroblasts in Bladder Urothelial Carcinoma. Nature Communications, 11, 5077. [Google Scholar] [CrossRef] [PubMed]
[9] Thongchot, S., Vidoni, C., Ferraresi, A., et al. (2021) Can-cer-Associated Fibroblast-Derived IL-6 Determines Unfavorable Prognosis in Cholangiocarcinoma by Affecting Au-tophagy-Associated Chemoresponse. Cancers (Basel), 13, 2134. [Google Scholar] [CrossRef] [PubMed]
[10] 郭嘉欣, 徐远义. 胃癌癌相关成纤维细胞研究进展[J]. 解放军医学杂志, 2021, 46(3): 306-310.
[11] Yang, R., Wang, D., Han, S., et al. (2022) MiR-206 Suppresses the Deterioration of Intrahepatic Cholangiocarcinoma and Promotes Sen-sitivity to Chemotherapy by Inhibiting Interactions with Stromal CAFs. International Journal of Biological Sciences, 18, 43-64. [Google Scholar] [CrossRef] [PubMed]
[12] Zhang, H., Deng, T., Liu, R., et al. (2020) CAF Secreted miR-522 Suppresses Ferroptosis and Promotes Acquired Chemo-Resistance in Gastric Cancer. Molecular Cancer, 19, 43. [Google Scholar] [CrossRef] [PubMed]
[13] Chen, Y., Song, Y., Du, W., et al. (2019) Tumor-Associated Macrophages: An Accomplice in Solid Tumor Progression. Journal of Biomedical Science, 26, 78. [Google Scholar] [CrossRef] [PubMed]
[14] Mantovani, A., Marchesi, F., Jaillon, S., et al. (2021) Tu-mor-Associated Myeloid Cells: Diversity and Therapeutic Targeting. Cellular & Molecular Immunology, 18, 566. [Google Scholar] [CrossRef] [PubMed]
[15] Laviron, M. and Boissonnas, A. (2019) Ontogeny of Tu-mor-Associated Macrophages. Frontiers in Immunology, 10, Article No. 1799. [Google Scholar] [CrossRef] [PubMed]
[16] O’Neill, L.A., Kishton, R.J. and Rathmell, J. (2016) A Guide to Immunometabolism for Immunologists. Nature Reviews Immunology, 16, 553-565. [Google Scholar] [CrossRef] [PubMed]
[17] Mai, S.J., Liu, L., Jiang, J.J., et al. (2021) Oesophageal Squamous Cell Carcinoma-Associated IL-33 Rewires Macrophage Polarization towards M2 via Activating Ornithine Decarboxylase. Cell Proliferation, 54, e12960. [Google Scholar] [CrossRef] [PubMed]
[18] Shen, Z.L., Yan, Y.C., Ye, C., et al. (2016) The Effect of Vasohibin-1 Ex-pression and Tumor-Associated Macrophages on the Angiogenesis in Vitro and in Vivo. Tumor Biology, 37, 7267-7276. [Google Scholar] [CrossRef] [PubMed]
[19] Yang, J., Li, X., Liu, X., et al. (2015) The Role of Tu-mor-Associated Macrophages in Breast Carcinoma Invasion and Metastasis. International Journal of Clinical and Ex-perimental Pathology, 8, 6656-6664.
[20] Farmaki, E., Kaza, V., Chatzistamou, I., et al. (2020) CCL8 Promotes Post-partum Breast Cancer by Recruiting M2 Macrophages. iScience, 23, Article ID: 101217. [Google Scholar] [CrossRef] [PubMed]
[21] Yoshie, O. and Matsushima, K. (2014) CCR4 and Its Ligands: From Bench to Bedside. International Immunology, 27, 11-20. [Google Scholar] [CrossRef] [PubMed]
[22] Lu, J., Kang, J., Zhang, C., et al. (2015) The Role of IL-33/ST2L Signals in the Immune Cells. Immunology Letters, 164, 11-17. [Google Scholar] [CrossRef] [PubMed]
[23] Kowalik, M. (2011) Yes-Associated Protein Regulation of Adap-tive Liver Enlargement and Hepatocellular Carcinoma Development in Mice. Hepatology, 53, 2086-2096. [Google Scholar] [CrossRef] [PubMed]
[24] Leushacke, M. and Barker, N. (2012) Lgr5 and Lgr6 as Markers to Study Adult Stem Cell Roles in Self-Renewal and Cancer. Oncogene, 31, 3009. [Google Scholar] [CrossRef] [PubMed]
[25] Lei, X., Lei, Y., Li, J.K., et al. (2020) Immune Cells within the Tumor Microenvironment: Biological Functions and Roles in Cancer Immunotherapy. Cancer Letters, 470, 126-133. [Google Scholar] [CrossRef] [PubMed]
[26] Gavrielatou, N., Vathiotis, I., Economopoulou, P., et al. (2021) The Role of B Cells in Head and Neck Cancer. Cancers (Basel), 13, 5383. [Google Scholar] [CrossRef] [PubMed]
[27] Yang, B., Zhang, Z., Chen, X., et al. (2022) An Asian-Specific Var-iant in Human IgG1 Represses Colorectal Tumorigenesis by Shaping the Tumor Microenvironment. Journal of Clinical Investigation, 132, e153454. [Google Scholar] [CrossRef] 
[28] Suarez-Sanchez, F.J., Lequerica-Fernandez, P., Rodrigo, J.P., et al. (2021) Tumor-Infiltrating CD20(+) B Lymphocytes: Significance and Prognostic Implications in Oral Cancer Microenvironment. Cancers (Basel), 13, 395. [Google Scholar] [CrossRef] [PubMed]
[29] Zhao, X., Liu, J., Ge, S., et al. (2019) Saikosaponin A Inhibits Breast Cancer by Regulating Th1/Th2 Balance. Frontiers in Pharmacology, 10, 624. [Google Scholar] [CrossRef] [PubMed]
[30] Cui, C., Wang, J., Fagerberg, E., et al. (2021) Neoantigen-Driven B Cell and CD4 T Follicular Helper Cell Collaboration Promotes Anti-Tumor CD8 T Cell Responses. Cell, 184, 6101-6118e13. [Google Scholar] [CrossRef] [PubMed]
[31] Peiffer, L., Farahpour, F., Sriram, A., et al. (2020) BRAF and MEK Inhibition in Melanoma Patients Enables Reprogramming of Tumor Infiltrating Lymphocytes. Cancer Immunology, Immunotherapy, 70, 1635-1674. [Google Scholar] [CrossRef] [PubMed]
[32] Lee, K.E., Spata, M., Bayne, L.J., et al. (2016) Hif1a Deletion Reveals Pro-Neoplastic Function of B Cells in Pancreatic Neoplasia. Cancer Discovery, 6, 256-269. [Google Scholar] [CrossRef] 
[33] Affara, N.I., Ruffell, B., Medler, T.R., et al. (2014) B Cells Regulate Macrophage Phenotype and Response to Chemotherapy in Squamous Carcinomas. Cancer Cell, 25, 809-821. [Google Scholar] [CrossRef] [PubMed]
[34] Allegra, C.J., Yothers, G., O’Connell, M.J., et al. (2012) Bevaci-zumab in Stage II-III Colon Cancer: 5-Year Update of the National Surgical Adjuvant Breast and Bowel Project C-08 Trial. Journal of Clinical Oncology, 31, 359-364. [Google Scholar] [CrossRef] 

为你推荐